
Authors of an oral abstract at the 2022 ASDS Annual Meeting presented their findings on the demographics of who requests total body skin exams to screen for skin cancer.

Authors of an oral abstract at the 2022 ASDS Annual Meeting presented their findings on the demographics of who requests total body skin exams to screen for skin cancer.

As the American Society for Dermatologic Surgery (ASDS) Annual Meeting begins today, Sue Ellen Cox, MD, president of ASDS, participated in a Q&A session.

Patricia Farris, MD, dermatologist from Metairie, Louisiana, discusses why the American Society for Dermatologic Surgery (ASDS) Annual Meeting is one of her favorite conferences to attend.

The 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting officially begins today in Denver, Colorado, and continues through October 10th.

SUNSHINE and SUNRISE trials showed superior efficacy over the placebo.

At the 2022 Skin of Color Update meeting in New York City, Saakshi Khattri, MD, talks about the benefits of treating patients who have psoriasis with roflumilast cream.

Taking a deep dive into alopecia areata allows for a better understanding of the cells that are responsible for disease development.

At the Skin of Color Update meeting in New York City, Mona Shahriari, MD, FAAD, shares her thoughts on prescribing the recently-approved tapinarof (VTAMA) for plaque psoriasis.

At a poster session at the Skin of Color Update meeting in New York City, a study looked at whether women of color thought they were well-represented when it comes to learning about skin aging and prevention.

At the Skin of Color Update 2022 meeting, Pearl Grimes, MD, shares her thoughts on the recent approval of ruxolitinib cream.

Study data was presented at EADV 2022 regarding socioeconomic status related to HS.

Hilary Baldwin, MD, discusses what's new and exciting at the Skin of Color Update Meeting in NYC

The relationship between transplant patients and basal cell carcinoma was discussed at EADV Congress 2022 in Milan, Italy.

TMB-001 showed positive results in the reduction of congenital ichthyosis severity in a phase 2b CONTROL study.

New sticky tape study can help predict onset of pediatric atopic eczema in babies.

Arcutis to present data from topical roflumilast clinical program at EADV 2022 Congress.

Abstracts will include updates on treatment for psoriatic arthritis, psoriasis, atopic dermatitis, and more.

At the SPD 2022 47th Annual Meeting, we chat with Albert Yan, MD, of Children's Hospital of Philadelphia on the latest trends in technology for pediatric dermatologists.

Kenneth Gordon, MD, professor and chair of dermatology at the Medical College of Wisconsin, discusses new topical therapy treatment options for psoriasis and what he's looking forward to.

Melodie Young, MSN, A/GNP-C, nurse practitioner at Mindful Dermatology and a partner and sub-investigator with Modern Research Associates in Dallas, Texas, explains what NPs and PAs can bring to the dermatology space.

Meena Julapalli, MD, notes the sessions she is most looking forward to at the 2022 SPD 47th Annual Meeting in Indianapolis, Indiana.

Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine, discusses new treatments and therapies for pediatric atopic dermatitis.

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains dives into what 2022 is bringing to the AD space.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the treatments for psoriatic arthritis, the comorbidities that have to be considered, and more.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, gives keys pearls on fillers and neuromodulators and what innovation is heading for the industry.

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains what allied health care workers can learn from his presentation.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the future of psoriatic arthritis.

James Treat, MD, dives into pediatric patients dealing with alopecia areata, sleep issues in children with atopic dermatitis, and more.

George Martin, MD and Ted Rosen, MD gave a 2-part comprehensive presentation on the changing landscape of cutaneous oncology at Maui Derm NP + PA Summer 2022.